Civil Hospices of Lyon
Autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS) are rare disease that could be difficult to diagnose. So it necessary to obtain numerous sample from different disease to develop more specific diagnosis kit It could be possible through the characterisation of new genetic biomarkers.
Parkinson's Disease; Amyotrophic Lateral Sclerosis; Glioblastoma; Cancer Without Neurological Disease; Rheumatoid Polyarthritis
Collection of biological sample (blood and/or CSF)
Not Applicable
| Study Type : | Interventional |
| Estimated Enrollment : | 350 participants |
| Masking : | None (Open Label) |
| Primary Purpose : | Diagnostic |
| Official Title : | Control Cohort CTRL COH |
| Actual Study Start Date : | August 8, 2023 |
| Estimated Primary Completion Date : | August 8, 2028 |
| Estimated Study Completion Date : | August 8, 2028 |
| Arm | Intervention/treatment |
|---|---|
|
Other: Control cohort Patient with following disease: Parkinson's disease, Amyotrophic lateral sclerosis, Glioblastoma, cancer without neurological disease (pulmonary cancer, breast cancer, ovarian cancer, melanoma, thymoma), rheumatoid arthritis. |
Biological: Collection of biological sample (blood and/or CSF) |
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Recruiting
Civil Hospices of Lyon
Bron, France, 69500